製剤開発アウトソーシング市場：サービス別、剤形別、用途別-2025-2030年の世界予測

製剤開発アウトソーシング市場の2023年の市場規模は400億1,000万米ドルで、2024年には437億6,000万米ドルに達すると予測され、CAGR 9.85％で成長し、2030年には772億6,000万米ドルに達すると予測されています。

製剤開発アウトソーシングでは、医薬品開発プロセスに不可欠な製剤の革新と最適化のために、専門の製薬会社と契約することが含まれます。その必要性は、複雑な製剤課題を克服し、バイオアベイラビリティを最適化し、安定性を確保し、規制要件を満たしながら、市場投入までの時間を短縮するための専門知識の必要性から生じる。用途は、がん、神経、感染症など複数の治療分野にまたがり、最終用途は主に製薬およびバイオテクノロジー業界です。市場開拓は、費用対効果の高い医薬品開発に対する需要の高まり、複雑で生物学的な医薬品分子の増加、社内のリソースを欠く中小バイオテクノロジー企業の急増などの影響を受けています。先端ドラッグデリバリーシステム、個別化医療のタッチポイント、デジタル技術を活用した製剤プロセスの強化など、サービス提供の拡大にビジネスチャンスがあります。企業への提言としては、予測的製剤化とプロセス効率向上のためのAIや機械学習などの技術プラットフォームへの投資、サービスポートフォリオを強化するための戦略的パートナーシップの形成などが挙げられます。

しかし、この市場は、厳しい規制状況、知的財産権に関する懸念、技術導入コストの高さといった課題に直面しています。さらに、大企業の社内開発能力や、アウトソーシング・モデル特有の品質管理問題のリスクによる競合圧力もあります。成長を促進するための技術革新分野としては、持続可能な製剤のための生分解性ポリマー、標的ドラッグデリバリーのためのナノフォーミュレーション、連続製造プロセスの採用などが挙げられます。市場情勢を読み解くと、急速な技術進歩や共同研究によってダイナミックかつ高度に進化していることがわかる。各社が差別化を図る中で、多様な治療法や顧客のニーズを満たす包括的かつ柔軟なサービスソリューションの構築に重点を置くことが重要になります。学術研究機関との連携は、新たな調査手法へのアクセスや新たな動向の先取りにおいて大きな強みとなります。

市場力学：急速に進化する製剤開発アウトソーシング市場における主要市場インサイトの解明

製剤開発アウトソーシング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患や感染症への高い負担に起因する新薬需要の高まり
  • バイオアベイラビリティを向上させるための難水溶性化合物の開発に大きな注目が集まっています。
  • 世界の臨床試験の急増
• 市場抑制要因
  • 製剤開発アウトソーシングの高コスト
• 市場機会
  • 製剤開発アウトソーシングサービス向上のための研究開発費の増加
  • 製剤開発のための新技術の開発
• 市場の課題
  • 製剤開発アウトソーシングに関連する品質管理の複雑さ

ポーターの5つの力：製剤開発アウトソーシング市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、製剤開発アウトソーシング市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：製剤開発アウトソーシング市場における外部からの影響の把握

外部マクロ環境要因は、製剤開発アウトソーシング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析製剤開発アウトソーシング市場における競合情勢の把握

製剤開発アウトソーシング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス製剤開発アウトソーシング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、製剤開発アウトソーシング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨製剤開発アウトソーシング市場における成功への道筋を描く

製剤開発アウトソーシング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患や感染症の負担が大きいため、新薬の需要が高まっている
    • バイオアベイラビリティを向上させるために難水溶性化合物の開発に重点を置く
    • 世界中で急速に増加する臨床研究の数
  • 抑制要因
    • 製剤開発アウトソーシングのコストが高い
  • 機会
    • 製剤開発アウトソーシングサービスの向上に向けた研究開発費の増加
    • 処方開発のための新技術の開発
  • 課題
    • 製剤開発アウトソーシングに関連する品質管理の複雑さ
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 製剤開発アウトソーシング市場：サービス別

• 処方最適化
  • フェーズI
  • フェーズII
  • フェーズIII
  • フェーズIV
• 事前処方サービス
  • 分析サービス
  • 探索および前臨床サービス

第7章 製剤開発アウトソーシング市場剤形別

• 注射可能
• オーラル
• 話題

第8章 製剤開発アウトソーシング市場：用途別

• 心臓血管
• 遺伝性疾患
• 感染症
• 神経学
• 腫瘍学
• 呼吸器

第9章 南北アメリカの製剤開発アウトソーシング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の製剤開発アウトソーシング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの製剤開発アウトソーシング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AbbVie Inc.
• Aizant Drug Research Solutions Private Limited
• Cambrex Corporation
• Catalent Inc.
• Emergent Biosolutions Inc.
• Eurofins Scientific SE
• Intertek Group PLC
• Jubilant Pharmova Limited
• Lonza Group AG
• Piramal Group
• Quotient Sciences Limited
• Recipharm AB
• Samsung Biologics Co., Ltd.
• SGS S.A.
• Siegfried AG
• Syngene International Limited

LIST OF FIGURES

• FIGURE 1. FORMULATION DEVELOPMENT OUTSOURCING MARKET RESEARCH PROCESS
• FIGURE 2. FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. FORMULATION DEVELOPMENT OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. FORMULATION DEVELOPMENT OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. FORMULATION DEVELOPMENT OUTSOURCING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. FORMULATION DEVELOPMENT OUTSOURCING MARKET DYNAMICS
• TABLE 7. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DISCOVERY & PRECLINICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 46. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 47. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 48. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 49. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 73. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 74. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 75. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 76. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 78. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 79. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 80. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 81. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 164. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 165. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 166. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 167. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 184. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 185. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 186. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 187. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 189. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 190. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 191. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 192. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION OPTIMIZATION, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE-FORMULATION SERVICES, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 238. FORMULATION DEVELOPMENT OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 239. FORMULATION DEVELOPMENT OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023

The Formulation Development Outsourcing Market was valued at USD 40.01 billion in 2023, expected to reach USD 43.76 billion in 2024, and is projected to grow at a CAGR of 9.85%, to USD 77.26 billion by 2030.

Formulation Development Outsourcing involves contracting specialized pharmaceutical companies to innovate and optimize formulations for drug products, which is integral to the drug development process. The necessity arises from the need for expertise in navigating complex formulation challenges, optimizing bioavailability, ensuring stability, and meeting regulatory requirements, all while accelerating time to market. Application spans across multiple therapeutic areas, including oncology, neurology, and infectious diseases, with end-use primarily in pharmaceutical and biotechnology industries. Market growth is influenced by the rising demand for cost-effective drug development, the increase in complex and biological drug molecules, and the surge of small to medium-sized biotech firms lacking internal resources. Opportunities lie in expanding service offerings to include advanced drug delivery systems, personalized medicine touchpoints, and leveraging digital technologies for enhanced formulation processes. Recommendations for businesses include investing in technology platforms like AI and machine learning for predictive formulation and enhanced process efficiencies, and forming strategic partnerships to enhance service portfolios.

However, this market faces challenges such as stringent regulatory landscapes, IP concerns, and the high cost of technology adoption. Additionally, there is a competitive pressure from in-house development capabilities of larger firms and the risk of quality control issues inherent to outsourcing models. To foster growth, areas of innovation include biodegradable polymers for sustainable formulations, nanoformulation for targeted drug delivery, and adoption of continuous manufacturing processes. Insight into the market's nature reveals a dynamic and highly evolving landscape driven by rapid technological advancements and collaborations. As companies strive for differentiation, an emphasis on building comprehensive and flexible service solutions that meet diverse therapeutic and client needs will be critical. Engaging in collaboration with academic research institutions can provide a significant edge in accessing novel formulation methodologies and staying ahead of emerging trends.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Formulation Development Outsourcing Market

The Formulation Development Outsourcing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing demand for new drugs owing to the high burden of chronic and infectious diseases
  • Huge focus on developing poorly water-soluble compounds to improve bioavailability
  • Rapidly growing number of clinical studies globally
• Market Restraints
  • High cost of formulation development outsourcing
• Market Opportunities
  • Increasing R&D spending to improve the formulation development outsourcing services
  • Development of new technologies for formulation development
• Market Challenges
  • Quality control complexities associated with formulation development outsourcing

Porter's Five Forces: A Strategic Tool for Navigating the Formulation Development Outsourcing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Formulation Development Outsourcing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Formulation Development Outsourcing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Formulation Development Outsourcing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Formulation Development Outsourcing Market

A detailed market share analysis in the Formulation Development Outsourcing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Formulation Development Outsourcing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Formulation Development Outsourcing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Formulation Development Outsourcing Market

A strategic analysis of the Formulation Development Outsourcing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Formulation Development Outsourcing Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aizant Drug Research Solutions Private Limited, Cambrex Corporation, Catalent Inc., Emergent Biosolutions Inc., Eurofins Scientific SE, Intertek Group PLC, Jubilant Pharmova Limited, Lonza Group AG, Piramal Group, Quotient Sciences Limited, Recipharm AB, Samsung Biologics Co., Ltd., SGS S.A., Siegfried AG, and Syngene International Limited.

Market Segmentation & Coverage

This research report categorizes the Formulation Development Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Service, market is studied across Formulation Optimization and Pre-formulation Services. The Formulation Optimization is further studied across Phase I, Phase II, Phase III, and Phase IV. The Pre-formulation Services is further studied across Analytical Services and Discovery & Preclinical Services.
• Based on Dosage Form, market is studied across Injectable, Oral, and Topical.
• Based on Application, market is studied across Cardiovascular, Genetic Disorders, Infectious Diseases, Neurology, Oncology, and Respiratory.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing demand for new drugs owing to the high burden of chronic and infectious diseases
    • 5.1.1.2. Huge focus on developing poorly water-soluble compounds to improve bioavailability
    • 5.1.1.3. Rapidly growing number of clinical studies globally
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of formulation development outsourcing
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing R&D spending to improve the formulation development outsourcing services
    • 5.1.3.2. Development of new technologies for formulation development
  • 5.1.4. Challenges
    • 5.1.4.1. Quality control complexities associated with formulation development outsourcing
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Formulation Development Outsourcing Market, by Service

• 6.1. Introduction
• 6.2. Formulation Optimization
  • 6.2.1. Phase I
  • 6.2.2. Phase II
  • 6.2.3. Phase III
  • 6.2.4. Phase IV
• 6.3. Pre-formulation Services
  • 6.3.1. Analytical Services
  • 6.3.2. Discovery & Preclinical Services

7. Formulation Development Outsourcing Market, by Dosage Form

• 7.1. Introduction
• 7.2. Injectable
• 7.3. Oral
• 7.4. Topical

8. Formulation Development Outsourcing Market, by Application

• 8.1. Introduction
• 8.2. Cardiovascular
• 8.3. Genetic Disorders
• 8.4. Infectious Diseases
• 8.5. Neurology
• 8.6. Oncology
• 8.7. Respiratory

9. Americas Formulation Development Outsourcing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Formulation Development Outsourcing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Formulation Development Outsourcing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Aizant Drug Research Solutions Private Limited
• 3. Cambrex Corporation
• 4. Catalent Inc.
• 5. Emergent Biosolutions Inc.
• 6. Eurofins Scientific SE
• 7. Intertek Group PLC
• 8. Jubilant Pharmova Limited
• 9. Lonza Group AG
• 10. Piramal Group
• 11. Quotient Sciences Limited
• 12. Recipharm AB
• 13. Samsung Biologics Co., Ltd.
• 14. SGS S.A.
• 15. Siegfried AG
• 16. Syngene International Limited